Esperion Therapeutics Inc
NASDAQ:ESPR

Watchlist Manager
Esperion Therapeutics Inc Logo
Esperion Therapeutics Inc
NASDAQ:ESPR
Watchlist
Price: 4.04 USD 2.28% Market Closed
Market Cap: 965.8m USD

Intrinsic Value

The intrinsic value of one ESPR stock under the Base Case scenario is hidden USD. Compared to the current market price of 4.04 USD, Esperion Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

ESPR Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Esperion Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

ESPR looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if ESPR is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about ESPR?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ESPR valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Esperion Therapeutics Inc.

Explain Valuation
Compare ESPR to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ESPR?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Esperion Therapeutics Inc

Current Assets 360.5m
Cash & Short-Term Investments 92.4m
Receivables 119m
Other Current Assets 149m
Non-Current Assets 3.6m
PP&E 3.5m
Intangibles 56k
Current Liabilities 359m
Accounts Payable 77.5m
Accrued Liabilities 101.2m
Other Current Liabilities 180.4m
Non-Current Liabilities 456.3m
Long-Term Debt 448.1m
Other Non-Current Liabilities 8.2m
Efficiency

Free Cash Flow Analysis
Esperion Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Esperion Therapeutics Inc

Revenue
303.8m USD
Cost of Revenue
-127m USD
Gross Profit
176.8m USD
Operating Expenses
-206.2m USD
Operating Income
-29.4m USD
Other Expenses
-76.5m USD
Net Income
-105.8m USD
Fundamental Scores

ESPR Profitability Score
Profitability Due Diligence

Esperion Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
ROIC is Increasing
Exceptional ROE
Exceptional Gross Margin
hidden
Profitability
Score

Esperion Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ESPR Solvency Score
Solvency Due Diligence

Esperion Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
hidden
Solvency
Score

Esperion Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ESPR Price Targets Summary
Esperion Therapeutics Inc

Wall Street analysts forecast ESPR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ESPR is 6.59 USD with a low forecast of 1.74 USD and a high forecast of 16.8 USD.

Lowest
Price Target
1.74 USD
57% Downside
Average
Price Target
6.59 USD
63% Upside
Highest
Price Target
16.8 USD
316% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Esperion Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ESPR is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ESPR Insider Trading
Buy and sell transactions by insiders

ESPR News

Other Videos
What is the Intrinsic Value of one ESPR stock?

The intrinsic value of one ESPR stock under the Base Case scenario is hidden USD.

Is ESPR stock undervalued or overvalued?

Compared to the current market price of 4.04 USD, Esperion Therapeutics Inc is hidden .

Back to Top